These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7935616)

  • 1. Cleavable complex formation in Leishmania chagasi treated with anilinoacridines.
    Werbovetz KA; Spoors PG; Pearson RD; Macdonald TL
    Mol Biochem Parasitol; 1994 May; 65(1):1-10. PubMed ID: 7935616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
    Tang SC; Shapiro TA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):620-6. PubMed ID: 20008775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mitonafide analogs on topoisomerase II of Leishmania chagasi.
    Slunt KM; Grace JM; Macdonald TL; Pearson RD
    Antimicrob Agents Chemother; 1996 Mar; 40(3):706-9. PubMed ID: 8851597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.
    Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM
    Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial Mechanism of Diamidines Involves Targeting Kinetoplasts.
    Yang G; Choi G; No JH
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6828-6836. PubMed ID: 27600039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs.
    Shapiro TA; Englund PT
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):950-4. PubMed ID: 2153980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles.
    Shapiro TA; Showalter AF
    Mol Cell Biol; 1994 Sep; 14(9):5891-7. PubMed ID: 8065322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial topoisomerase II activity is essential for kinetoplast DNA minicircle segregation.
    Shapiro TA
    Mol Cell Biol; 1994 Jun; 14(6):3660-7. PubMed ID: 8196610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.
    Mittra B; Saha A; Chowdhury AR; Pal C; Mandal S; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
    Mol Med; 2000 Jun; 6(6):527-41. PubMed ID: 10972088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.
    Cavalcanti DP; Fragoso SP; Goldenberg S; de Souza W; Motta MC
    Parasitol Res; 2004 Dec; 94(6):439-48. PubMed ID: 15517387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II topoisomerase activity in trypanosome mitochondria.
    Shapiro TA; Klein VA; Englund PT
    J Biol Chem; 1989 Mar; 264(7):4173-8. PubMed ID: 2537308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetoplast-associated DNA topoisomerase in Crithidia fasciculata: crosslinking of mitochondrial topoisomerase II to both minicircles and maxicircles in cells treated with the topoisomerase inhibitor VP16.
    Ray DS; Hines JC; Anderson M
    Nucleic Acids Res; 1992 Jul; 20(13):3353-6. PubMed ID: 1321413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Leishmania chagasi DNA topoisomerase II: a potential chemotherapeutic target.
    De Sousa JM; Lareau SM; Pearson RD; Carvalho EM; Mann BJ; Jeronimo SM
    Scand J Infect Dis; 2003; 35(11-12):826-9. PubMed ID: 14723357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
    Barret JM; Calsou P; Larsen AK; Salles B
    Mol Pharmacol; 1994 Sep; 46(3):431-6. PubMed ID: 7935322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targets in kinetoplastid parasites. Preface.
    Majumder HK
    Adv Exp Med Biol; 2008; 625():vii-viii. PubMed ID: 18365653
    [No Abstract]   [Full Text] [Related]  

  • 16. Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Robinson MJ; Osheroff N
    Biochemistry; 1990 Mar; 29(10):2511-5. PubMed ID: 2159323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum.
    Nguewa PA; Fuertes MA; Iborra S; Najajreh Y; Gibson D; Martínez E; Alonso C; Pérez JM
    J Inorg Biochem; 2005 Mar; 99(3):727-36. PubMed ID: 15708793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The steroid derivative 6-aminocholestanol inhibits the DEAD-box helicase eIF4A (LieIF4A) from the Trypanosomatid parasite Leishmania by perturbing the RNA and ATP binding sites.
    Abdelkrim YZ; Harigua-Souiai E; Barhoumi M; Banroques J; Blondel A; Guizani I; Tanner NK
    Mol Biochem Parasitol; 2018 Dec; 226():9-19. PubMed ID: 30365976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and structural analysis of AT-specific minor groove binders that disrupt DNA-protein interactions and cause disintegration of the Trypanosoma brucei kinetoplast.
    Millan CR; Acosta-Reyes FJ; Lagartera L; Ebiloma GU; Lemgruber L; Nué Martínez JJ; Saperas N; Dardonville C; de Koning HP; Campos JL
    Nucleic Acids Res; 2017 Aug; 45(14):8378-8391. PubMed ID: 28637278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs affecting trypanosome topoisomerases.
    Shapiro TA
    Adv Pharmacol; 1994; 29B():187-200. PubMed ID: 8996608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.